{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:28:25Z","timestamp":1783038505254,"version":"3.54.6"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.ijcard.2006.07.045","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T13:07:09Z","timestamp":1180962429000},"page":"41-47","source":"Crossref","is-referenced-by-count":15,"title":["Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment"],"prefix":"10.1016","volume":"119","author":[{"given":"L.","family":"Puccetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Pasqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pastorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Palazzuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pontani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Auteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2006.07.045_bib1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00041433-200212000-00007","article-title":"Safety considerations for statins","volume":"13","author":"Bolego","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ijcard.2006.07.045_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(99)00525-2","article-title":"The evolving role of statins in the management of atherosclerosis","volume":"35","author":"Vaughan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2006.07.045_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,356 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2006.07.045_bib4","first-page":"328","article-title":"Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?","volume":"11","author":"Comparato","year":"2001","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.ijcard.2006.07.045_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.ATV.15.2.247","article-title":"Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia","volume":"15","author":"Notarbartolo","year":"1995","journal-title":"Artrioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2006.07.045_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1160\/TH03-02-0111","article-title":"Platelet hyperactivity after statin treatment discontinuation","volume":"90","author":"Puccetti","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijcard.2006.07.045_bib7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2362.2002.01086.x","article-title":"Time-dependent effect of statins on platelet function in hypercholesterolemic subjects","volume":"32","author":"Puccetti","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ijcard.2006.07.045_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2006.07.045_bib9","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1161\/01.CIR.93.9.1740","article-title":"Oxidized LDL decreases l-arginine uptake and nitric oxide syntase protein expression in human platelets. Relevance of the effect of oxidized LDL on platelet function","volume":"93","author":"Chen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.07.045_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0143-4160(96)90118-9","article-title":"Oxidized low density lipoprotein inhibits platelet plasma membrane Ca2+-ATPase","volume":"19","author":"Zhao","year":"1996","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ijcard.2006.07.045_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0014-5793(99)01762-7","article-title":"Mildly oxidized low density lipoprotein induces platelet shape change via Rho-kinase-dependent phosphorylation of myosin light chain and moesin","volume":"446","author":"Retzer","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ijcard.2006.07.045_bib12","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1161\/01.ATV.17.11.3230","article-title":"In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia","volume":"17","author":"Dav\u00ec","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2006.07.045_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2362.2005.01446.x","article-title":"Effect of statins on platelet oxidized-LDL receptors expression in hypercholesterolemic subjects","volume":"35","author":"Puccetti","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ijcard.2006.07.045_bib14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/jmg.40.12.933","article-title":"Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction","volume":"40","author":"Mango","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.ijcard.2006.07.045_bib15","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1161\/01.CIR.0000074207.85796.36","article-title":"Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease","volume":"107","author":"Chen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.07.045_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0006-291X(03)00326-7","article-title":"Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction","volume":"303","author":"Tatsuguchi","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijcard.2006.07.045_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cardiores.2005.09.006","article-title":"Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders","volume":"69","author":"Metha","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2006.07.045_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.atherosclerosis.2005.03.012","article-title":"3\u2032UTR\/T polymorphism of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is associated with modified anti-platelet activity of atorvastatin in hypercholesterolemic subjects","volume":"183","author":"Puccetti","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2006.07.045_bib19","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2006.07.045_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/386073a0","article-title":"An endothelial receptor for oxidized low-density lipoprotein","volume":"386","author":"Sawamura","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2006.07.045_bib21","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0735-1097(02)01803-X","article-title":"Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor","volume":"39","author":"Metha","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2006.07.045_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1254\/jphs.91.182","article-title":"Endothelial dysfunction via lectin-like oxidized low-density lipoprotein receptor-1: close relationship with oxidative stress","volume":"91","author":"Sakurai","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.ijcard.2006.07.045_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0735-1097(02)02811-5","article-title":"The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells","volume":"41","author":"Cominacini","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2006.07.045_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1006\/bbrc.2001.6070","article-title":"Inhibition of LOX-1 by statins may relate to upregulation of eNOS","volume":"289","author":"Metha","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijcard.2006.07.045_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11883-005-0031-3","article-title":"The lectin-like oxidized low-density lipoprotein receptor and its role in atherosclerosis","volume":"7","author":"Cilingiroglu","year":"2005","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ijcard.2006.07.045_bib26","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2006.07.045_bib27","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/01.ATV.0000140061.89096.2b","article-title":"Pro-inflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells","volume":"24","author":"Hofnagel","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2006.07.045_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.ATV.0000157979.51673.2c","article-title":"C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein","volume":"25","author":"van Tits","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2006.07.045_bib29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.fjc.0000140205.74180.3c","article-title":"Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis","volume":"44","author":"Chen","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ijcard.2006.07.045_bib30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/01.RES.0000174563.62625.8e","article-title":"In vivo and in vitro studies support that a new splicing isoform of ORL1 gene is protective against acute myocardial infarction","volume":"97","author":"Mango","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2006.07.045_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2006.07.045_bib32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jacc.2005.04.051","article-title":"Race and gender differences in C-reactive protein levels","volume":"46","author":"Khera","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2006.07.045_bib33","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1161\/01.CIR.0000023397.12047.03","article-title":"Statin therapy: beyond cholesterol lowering and anti-inflammatory effects","volume":"105","author":"Yeung","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.07.045_bib34","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1001\/jama.291.23.2821","article-title":"Pharmacogenetic study of statin therapy and cholesterol reduction","volume":"291","author":"Chasman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2006.07.045_bib35","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1161\/01.CIR.0000068311.40161.28","article-title":"Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events","volume":"107","author":"Boekholdt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.07.045_bib36","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jacc.2005.05.085","article-title":"Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis","volume":"46","author":"Robinson","year":"2005","journal-title":"J Am Coll Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527306008928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527306008928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T17:20:43Z","timestamp":1556472043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527306008928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0167527306008928"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2006.07.045","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}